Acumen Pharmaceuticals Stock Price on October 21, 2024
| ABOS Stock | USD 2.31 0.06 2.53% |
If you're considering investing in Acumen Stock, it is important to understand the factors that can impact its price. As of today, the current price of Acumen Pharmaceuticals stands at 2.31, as last reported on the 22nd of November, with the highest price reaching 2.40 and the lowest price hitting 2.25 during the day. Acumen Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0556, which signifies that the company had a -0.0556% return per unit of risk over the last 3 months. Acumen Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Acumen Pharmaceuticals' Mean Deviation of 3.52, standard deviation of 4.69, and Risk Adjusted Performance of (0.03) to double-check the risk estimate we provide.
Stock Based Compensation is likely to gain to about 6.5 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 143.2 M in 2024. . At this time, Acumen Pharmaceuticals' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 0.73 in 2024, whereas Price Earnings Ratio is likely to drop (3.73) in 2024. Acumen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Acumen |
Sharpe Ratio = -0.0556
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ABOS |
Estimated Market Risk
| 4.74 actual daily | 42 58% of assets are more volatile |
Expected Return
| -0.26 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Acumen Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Acumen Pharmaceuticals by adding Acumen Pharmaceuticals to a well-diversified portfolio.
Price Book 0.639 | Enterprise Value Ebitda (0.60) | Price Sales 538.7842 | Shares Float 32.4 M | Wall Street Target Price 10.8 |
Acumen Pharmaceuticals Main Headline on 21st of October 2024
3 US Penny Stocks With Market Caps Under 500M To Consider by simplywall.st
Major U.S. stock indices have recently slipped from record highs as investors brace for a wave of earnings reports, highlighting the markets ongoing volatility and uncertainty. Despite these fluctuations, penny stocks continue to present intriguing opportunities for investors looking to explore potential growth in smaller or newer companies. While the term penny stock might seem outdated, these investments can still offer significant upside when backed by strong financials and sound...
Acumen Pharmaceuticals Valuation on October 21, 2024
It is possible to determine the worth of Acumen Pharmaceuticals on a given historical date. On October 21, 2024 Acumen was worth 2.85 at the beginning of the trading date compared to the closed value of 2.7. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Acumen Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Acumen Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Acumen Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Acumen Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 2.70 | 2.89 | 2.67 | 2.86 | 289,446 | |
10/21/2024 | 2.85 | 2.95 | 2.64 | 2.70 | 180,919 |
| 2.69 | 2.82 | 2.64 | 2.80 | 164,888 |
| Backtest Acumen Pharmaceuticals | | | Acumen Pharmaceuticals History | | | Acumen Pharmaceuticals Valuation | Previous | Next |
Acumen Pharmaceuticals Trading Date Momentum on October 21, 2024
| On October 22 2024 Acumen Pharmaceuticals was traded for 2.80 at the closing time. The top price for the day was 2.82 and the lowest listed price was 2.64 . The trading volume for the day was 164.9 K. The trading history from October 22, 2024 was a factor to the next trading day price appreciation. The overall trading delta against the next closing price was 3.70% . The overall trading delta against the current closing price is 12.59% . |
Acumen Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Acumen Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Acumen Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Acumen financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Acumen Pharmaceuticals Stock history
Acumen Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Acumen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Acumen Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Acumen Pharmaceuticals stock prices may prove useful in developing a viable investing in Acumen Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 48.6 M | 46.2 M | |
| Net Loss | -38.6 M | -40.5 M |
Acumen Pharmaceuticals Quarterly Net Working Capital |
|
Acumen Pharmaceuticals Stock Technical Analysis
Acumen Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Acumen Pharmaceuticals Period Price Range
Low | November 22, 2024
| High |
0.00 | 0.00 |
Acumen Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Acumen Pharmaceuticals November 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Acumen Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Acumen Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Acumen Pharmaceuticals stock market strength indicators, traders can identify Acumen Pharmaceuticals entry and exit signals to maximize returns
Acumen Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Acumen Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Acumen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Acumen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.51) | |||
| Total Risk Alpha | (0.83) | |||
| Treynor Ratio | (0.07) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Acumen Stock Analysis
When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.